Primary Site >> Colorectal Cancer

Gene >> PTPN11

  • 1995
  • 2004
  • 2006
  • 2008
  • 2010
  • 2011
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Regulation of the Src tyrosine kinase and Syp tyrosine phosphatase by their cellular association.
PMID: 7478513
Ref: NSAIDs activate PTEN and other phosphatases in human colon cancer cells: novel mechanism for chemopreventive action of NSAIDs.
PMID: 15240129
Ref: Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2.
PMID: 16920701
Ref: SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients.
PMID: 18064648
Ref: Tyrosine phosphorylation of netrin receptors in netrin-1 signaling.
PMID: 18253061
Ref: Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T.
PMID: 20133777
Ref: Association of Shp2 with phosphorylated IL-22R1 is required for interleukin-22-induced MAP kinase activation.
PMID: 20671117
Ref: SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer.
PMID: 21528083
Ref: Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
PMID: 24173294
Ref: Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancer.
PMID: 24439672
Ref: Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling.
PMID: 24651526
Ref: YES oncogenic activity is specified by its SH4 domain and regulates RAS/MAPK signaling in colon carcinoma cells.
PMID: 26269757
Ref: PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer Drugs.
PMID: 26365186
Ref: SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis but prevents colitis-associated cancer development.
PMID: 27582544
Ref: T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice.
PMID: 27935860
Ref: The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer.
PMID: 28675510
Ref: Understanding and Resetting Radiation Sensitivity in Rectal Cancer.
PMID: 28742699
Ref: A Deregulated PI3K-AKT Signaling Pathway in Patients with Colorectal Cancer.
PMID: 29110225
Ref: SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer.
PMID: 29242509
Ref: The gain-of-function mutation E76K in SHP2 promotes CAC tumorigenesis and induces EMT via the Wnt/beta-catenin signaling pathway.
PMID: 29323748
Ref: BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.
PMID: 29326440
Ref: Racial Disparities in the Molecular Landscape of Cancer.
PMID: 29599344
Ref: Inflammatory genes are novel prognostic biomarkers for colorectal cancer.
PMID: 29693170
Ref: SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo.
PMID: 29808006
Ref: Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer.
PMID: 29987896
Ref: Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion.
PMID: 30107178